Paul M. Silva is VP & Controller at VERTEX PHARMACEUTICALS INC / MA (VRTX). They have made 52 open-market trades across 1 company since 2008, most recently 2021-03-01.
CIK 0001446372
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 52 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| VRTX | 9,884 | $4.9M |
Shares reported on the most recent Form 4, priced at the 2021-03-02 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VRTX | SELL | 2021-03-01 | 2021-03-02 | $211.38 | $1.1M | +1.1% | +0.5% | -1.1% |
| VRTX | SELL | 2021-02-25 | 2021-02-26 | $213.30 | $434K | +0.8% | +1.9% | -2.5% |
| VRTX | SELL | 2021-02-18 | 2021-02-19 | $211.83 | $1.8M | +0.8% | +5.9% | +4.8% |
| VRTX | SELL | 2021-02-11 | 2021-02-16 | $210.52 | $586K | +1.4% | +1.8% | +3.2% |
| VRTX | SELL | 2020-08-06 | 2020-08-10 | $271.11 | $564K | +2.0% | -1.1% | -16.2% |
| VRTX | SELL | 2020-08-03 | 2020-08-05 | $278.36 | $431K | +1.7% | -1.0% | -21.6% |
| VRTX | SELL | 2020-07-13 | 2020-07-15 | $292.70 | $325K | -2.7% | -8.5% | -5.5% |
| VRTX | SELL · 10b5-1 | 2020-05-15 | 2020-05-19 | $284.00 | $43K | +0.6% | -2.0% | -3.9% |
| VRTX | SELL | 2020-05-06 | 2020-05-08 | $272.97 | $506K | +4.9% | -2.4% | +0.7% |
| VRTX | SELL | 2020-05-04 | 2020-05-06 | $260.43 | $328K | +4.2% | -2.6% | +1.1% |
| VRTX | SELL · 10b5-1 | 2020-04-13 | 2020-04-15 | $248.72 | $214K | +3.4% | +11.2% | +13.2% |
| VRTX | SELL | 2020-04-06 | 2020-04-08 | $255.57 | $2.5M | +4.3% | +7.8% | +18.7% |
| VRTX | SELL | 2020-02-25 | 2020-02-26 | $232.66 | $317K | -3.9% | -4.9% | +16.6% |
| VRTX | SELL | 2020-02-18 | 2020-02-19 | $243.58 | $381K | -6.1% | -16.7% | +14.1% |
| VRTX | SELL | 2020-02-11 | 2020-02-12 | $246.28 | $2.1M | -4.7% | -8.5% | +14.5% |
| VRTX | SELL | 2020-02-06 | 2020-02-07 | $239.07 | $193K | +2.5% | -8.2% | +12.9% |
| VRTX | SELL | 2020-02-03 | 2020-02-05 | $231.06 | $873K | +1.6% | -3.6% | +12.5% |
| VRTX | SELL | 2020-01-31 | 2020-02-04 | $238.65 | $666K | +0.9% | -1.8% | +9.6% |
| VRTX | SELL | 2020-01-13 | 2020-01-15 | $229.38 | $395K | -1.0% | +4.1% | +12.0% |
| VRTX | SELL | 2020-01-08 | 2020-01-10 | $231.89 | $6.4M | +2.0% | +6.7% | +7.5% |
| VRTX | SELL | 2020-01-02 | 2020-01-06 | $218.97 | $9.0M | +5.0% | +7.4% | +13.8% |
| VRTX | SELL · 10b5-1 | 2019-05-15 | 2019-05-17 | $165.41 | $27K | +1.5% | +3.6% | +8.0% |
| VRTX | SELL | 2019-02-19 | 2019-02-21 | $186.91 | $1.0M | +1.9% | -0.3% | -6.5% |
| VRTX | SELL | 2019-02-11 | 2019-02-13 | $180.29 | $889K | +2.4% | +1.9% | -9.6% |
| VRTX | SELL | 2019-02-06 | 2019-02-07 | $193.00 | $249K | +5.1% | +1.0% | -5.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.